New Anti-Cancer Drug Class Market Opportunity Assessment
Case Study
Scenario:
- Start up drug development company developing new class of anti-cancer drugs needs market opportunity assessment and commercial overview for grant application
Background:
- Early stage drug development company was seeking to screen a class of compounds with anti-tumor activity to identify a lead candidate to take into pre-clinical development.
- Class of compounds under investigation has the ability to overcome many of the drawbacks encountered with taxanes, a commonly used class of anti-cancer drugs, and have therapeutic application across a range of solid tumor types.
- Company was applying for a grant to provide funding and needed a business plan overview and commercial justification section of grant application.
Objectives:
- Provide market landscape overview indicating size of market for targeted tumor types, current level of taxane use, and impact of newer taxane alternative chemotherapeutic agents.
- Hypothesize value proposition and competitive advantage required to overcome current and future competition.
- Write commercial sections of grant application.
Approach:
- Review of literature, secondary data and syndicated market reports
- Datamining of SEER-Medicare database to determine % of patients with target tumor types receiving taxanes
- External resources used:
- Multiple syndicated market reports
- Brief Literature search
- SEER-Medicare database
- Deliverables included writing of grant appliation commercial sections
Key Outcomes:
- Developed novel way to estimate number of patients receiving taxane therapy without incurring additional data procurement expenses. Taxane market used as early estimate new drug market size.
- Hypothesized ideal target product profile required for commercial success
Impact:
- Grant received funding
